Q72498 (Q72498_9HIV1) Human immunodeficiency virus 1

POL polyprotein UniProtKBInterProInteractive Modelling

1003 aa; Sequence (Fasta)

Available Structures

24 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Structural Basis for Inhibitor-Induced Aggregation of HIV-1 Integrasehomo-4-mer771-991
2SQ;
Assess
HIV-1 IN core domain in complex with 6-fluoro-1,3-benzothiazol-2-aminehomo-2-mer771-925
FBB;
Assess
HIV-1 IN core domain in complex with 4-(1H-pyrrol-1-yl)anilinehomo-2-mer771-924
GLC;CD;SO4;SNU;
Assess
HIV-1 IN core domain in complex with (1-methyl-5-phenyl-1H-pyrazol-4-yl)methanolhomo-2-mer771-924
CD;BCK;SO4;
Assess
Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrasehomo-2-mer771-924
GLC;SO4;MPV;CD;
Assess
Structure of HIV-1 integrase core domain in complex with sucrosehomo-2-mer771-924
GLC;SO4;CD;
Assess
Crystal structure of the HIV-1 integrase core domain to 1.4Ahomo-2-mer772-924
SO4;
Assess
HIV-1 IN core domain in complex with (3R)-3,4-dihydro-2H-chromen-3-ylmethanolhomo-2-mer772-924
CD;CL;SO4;BCU;
Assess
HIV-1 IN core domain in complex with [1-(4-fluorophenyl)-5-methyl-1H-pyrazol-4-yl]methanolhomo-2-mer772-924
CD;CL;SO4;FMQ;
Assess
HIV-1 IN core domain in complex with 1-benzothiophen-6-amine 1,1-dioxidehomo-2-mer771-923
GLC;CD;SO4;MWP;
Assess
Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrasehomo-2-mer772-924
CD;CL;BMC;SO4;
Assess
Fragments bound to HIV-1 integrasehomo-2-mer771-923
CD;SO4;0NX;
Assess
HIV-1 integrase core domain in complex with 2,1,3-benzothiadiazol-4-aminehomo-2-mer772-924
GLC;CD;SO4;BTE;
Assess
HIV-1 IN core domain in complex with 2,3-dihydro-1,4-benzodioxin-5-ylmethanolhomo-2-mer771-923
CD;CL;SO4;DBJ;
Assess
HIV-1 IN core domain in complex with 6-fluoro-4H-1,3-benzodioxine-8-carboxylic acidhomo-2-mer772-924
CD;SO4;FBG;
Assess
Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrasehomo-2-mer772-923
GLC;BBY;CL;SO4;CD;
Assess
Fragment-based approach to the design of ligands targeting a novel site in HIV-1 integrasehomo-2-mer772-923
CD;SO4;BZX;
Assess
HIV-1 IN core domain in complex with 5-methyl-3-phenyl-1,2-oxazole-4-carboxylic acidhomo-2-mer772-923
CD;SO4;MOK;
Assess
HIV-1 IN core domain in complex with (5-METHYL-3-PHENYL-1,2-OXAZOL-4-YL)METHANOLhomo-2-mer772-923
CD;SO4;MPK;
Assess
HIV-1 IN core domain in complex with N-METHYL-1-(4-METHYL-2-PHENYL-1,3-THIAZOL-5-YL)METHANAMINEhomo-2-mer772-922
CD;CL;SO4;MMJ;
Assess
Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrasehomo-2-mer772-922
CD;CL;SO4;833;
Assess
a novel 13-ring macrocyclic HIV-1 protease inhibitors involving the P1'-P2' ligandshomo-2-mer57-155
NA;CL;GR7;GOL;ACT;
Assess
a hydroxymethyl functionality at the 4-position of the 2-phenyloxazole moiety of HIV-1 protease inh…homo-2-mer57-155
G53;NA;CL;
Assess
Crystal structure of HIV-1 Protease NL4-3 WT in complex with darunavirhomo-2-mer57-155
017;SO4;
Assess

8 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4zhr.1.Amonomer0.80156-708
99.46
Assess
6rwl.1.Bmonomer0.74716-987
ZN;75.35
Assess
6rwl.1.Amonomer0.74716-984
ZN;75.35
Assess
5u1c.1.Amonomer0.73738-984
95.86
Assess
3kt2.1.Amonomer0.7331-155
86.55
Assess
7sep.1.Bmonomer0.71162-583
96.80
Assess
5u1c.1.Bmonomer0.70771-984
95.86
Assess
5dzm.6.Amonomer0.65582-693
94.81
Assess